1 Dermatology Diagnostic Devices and Therapeutics Market Overview
1.1 Product Overview and Scope of Dermatology Diagnostic Devices and Therapeutics
1.2 Dermatology Diagnostic Devices and Therapeutics Segment by Type
1.2.1 Global Dermatology Diagnostic Devices and Therapeutics Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Product Dermatoscopes
1.2.3 Product Microscopes and Trichoscopes
1.2.4 Product Imaging Equipment
1.2.5 Others
1.3 Dermatology Diagnostic Devices and Therapeutics Segment by Application
1.3.1 Dermatology Diagnostic Devices and Therapeutics Sales Comparison by Application: (2020-2026)
1.3.2 Antibacterial Agents
1.3.3 Antifungal Agents
1.3.4 Antiviral Agents
1.3.5 Others
1.4 Global Dermatology Diagnostic Devices and Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Dermatology Diagnostic Devices and Therapeutics Revenue 2015-2026
1.4.2 Global Dermatology Diagnostic Devices and Therapeutics Sales 2015-2026
1.4.3 Dermatology Diagnostic Devices and Therapeutics Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Dermatology Diagnostic Devices and Therapeutics Industry Impact
1.5.1 How the Covid-19 is Affecting the Dermatology Diagnostic Devices and Therapeutics Industry
1.5.1.1 Dermatology Diagnostic Devices and Therapeutics Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dermatology Diagnostic Devices and Therapeutics Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dermatology Diagnostic Devices and Therapeutics Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered
2 Global Dermatology Diagnostic Devices and Therapeutics Market Competition by Manufacturers
2.1 Global Dermatology Diagnostic Devices and Therapeutics Sales Market Share by Manufacturers (2015-2020)
2.2 Global Dermatology Diagnostic Devices and Therapeutics Revenue Share by Manufacturers (2015-2020)
2.3 Global Dermatology Diagnostic Devices and Therapeutics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Dermatology Diagnostic Devices and Therapeutics Manufacturing Sites, Area Served, Product Type
2.5 Dermatology Diagnostic Devices and Therapeutics Market Competitive Situation and Trends
2.5.1 Dermatology Diagnostic Devices and Therapeutics Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Dermatology Diagnostic Devices and Therapeutics Players (Opinion Leaders)
3 Dermatology Diagnostic Devices and Therapeutics Retrospective Market Scenario by Region
3.1 Global Dermatology Diagnostic Devices and Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Dermatology Diagnostic Devices and Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Dermatology Diagnostic Devices and Therapeutics Market Facts & Figures by Country
3.3.1 North America Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.3.2 North America Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dermatology Diagnostic Devices and Therapeutics Market Facts & Figures by Country
3.4.1 Europe Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.4.2 Europe Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Market Facts & Figures by Region
3.5.1 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Sales by Region
3.5.2 Asia Pacific Dermatology Diagnostic Devices and Therapeutics Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dermatology Diagnostic Devices and Therapeutics Market Facts & Figures by Country
3.6.1 Latin America Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.6.2 Latin America Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dermatology Diagnostic Devices and Therapeutics Market Facts & Figures by Country
3.7.1 Middle East and Africa Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.7.2 Middle East and Africa Dermatology Diagnostic Devices and Therapeutics Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Dermatology Diagnostic Devices and Therapeutics Historic Market Analysis by Type
4.1 Global Dermatology Diagnostic Devices and Therapeutics Sales Market Share by Type (2015-2020)
4.2 Global Dermatology Diagnostic Devices and Therapeutics Revenue Market Share by Type (2015-2020)
4.3 Global Dermatology Diagnostic Devices and Therapeutics Price Market Share by Type (2015-2020)
4.4 Global Dermatology Diagnostic Devices and Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Dermatology Diagnostic Devices and Therapeutics Historic Market Analysis by Application
5.1 Global Dermatology Diagnostic Devices and Therapeutics Sales Market Share by Application (2015-2020)
5.2 Global Dermatology Diagnostic Devices and Therapeutics Revenue Market Share by Application (2015-2020)
5.3 Global Dermatology Diagnostic Devices and Therapeutics Price by Application (2015-2020)
6 Company Profiles and Key Figures in Dermatology Diagnostic Devices and Therapeutics Business
6.1 Michelson Diagnostics Ltd.
6.1.1 Corporation Information
6.1.2 Michelson Diagnostics Ltd. Description, Business Overview
6.1.3 Michelson Diagnostics Ltd. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Michelson Diagnostics Ltd. Products Offered
6.1.5 Michelson Diagnostics Ltd. Recent Development
6.2 Canfield Scientific, Inc.
6.2.1 Corporation Information
6.2.2 Canfield Scientific, Inc. Description, Business Overview
6.2.3 Canfield Scientific, Inc. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Canfield Scientific, Inc. Products Offered
6.2.5 Canfield Scientific, Inc. Recent Development
6.3 Astellas Pharma, Inc.
6.3.1 Corporation Information
6.3.2 Astellas Pharma, Inc. Description, Business Overview
6.3.3 Astellas Pharma, Inc. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Astellas Pharma, Inc. Products Offered
6.3.5 Astellas Pharma, Inc. Recent Development
6.4 GlaxoSmithKline plc
6.4.1 Corporation Information
6.4.2 GlaxoSmithKline plc Description, Business Overview
6.4.3 GlaxoSmithKline plc Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GlaxoSmithKline plc Products Offered
6.4.5 GlaxoSmithKline plc Recent Development
6.5 Novartis International AG
6.5.1 Corporation Information
6.5.2 Novartis International AG Description, Business Overview
6.5.3 Novartis International AG Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Novartis International AG Products Offered
6.5.5 Novartis International AG Recent Development
6.6 Dino-Lite Europe/IDCP B.V.
6.6.1 Corporation Information
6.6.2 Dino-Lite Europe/IDCP B.V. Description, Business Overview
6.6.3 Dino-Lite Europe/IDCP B.V. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Dino-Lite Europe/IDCP B.V. Products Offered
6.6.5 Dino-Lite Europe/IDCP B.V. Recent Development
6.7 Galderma S.A.
6.7.1 Corporation Information
6.7.2 Galderma S.A. Description, Business Overview
6.7.3 Galderma S.A. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.7.4 Galderma S.A. Products Offered
6.7.5 Galderma S.A. Recent Development
6.8 Cutera, Inc.
6.8.1 Corporation Information
6.8.2 Cutera, Inc. Description, Business Overview
6.8.3 Cutera, Inc. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Cutera, Inc. Products Offered
6.8.5 Cutera, Inc. Recent Development
6.9 gfa-Gevaert N.V.
6.9.1 Corporation Information
6.9.2 gfa-Gevaert N.V. Description, Business Overview
6.9.3 gfa-Gevaert N.V. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.9.4 gfa-Gevaert N.V. Products Offered
6.9.5 gfa-Gevaert N.V. Recent Development
6.10 Genentech
6.10.1 Corporation Information
6.10.2 Genentech Description, Business Overview
6.10.3 Genentech Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Genentech Products Offered
6.10.5 Genentech Recent Development
6.11 Valeant Pharmaceuticals International, Inc.
6.11.1 Corporation Information
6.11.2 Valeant Pharmaceuticals International, Inc. Description, Business Overview
6.11.3 Valeant Pharmaceuticals International, Inc. Dermatology Diagnostic Devices and Therapeutics Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Valeant Pharmaceuticals International, Inc. Products Offered
6.11.5 Valeant Pharmaceuticals International, Inc. Recent Development
7 Dermatology Diagnostic Devices and Therapeutics Manufacturing Cost Analysis
7.1 Dermatology Diagnostic Devices and Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dermatology Diagnostic Devices and Therapeutics
7.4 Dermatology Diagnostic Devices and Therapeutics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dermatology Diagnostic Devices and Therapeutics Distributors List
8.3 Dermatology Diagnostic Devices and Therapeutics Customers
9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)
10 Global Market Forecast
10.1 Global Dermatology Diagnostic Devices and Therapeutics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dermatology Diagnostic Devices and Therapeutics by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Dermatology Diagnostic Devices and Therapeutics by Type (2021-2026)
10.2 Dermatology Diagnostic Devices and Therapeutics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dermatology Diagnostic Devices and Therapeutics by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Dermatology Diagnostic Devices and Therapeutics by Application (2021-2026)
10.3 Dermatology Diagnostic Devices and Therapeutics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dermatology Diagnostic Devices and Therapeutics by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Dermatology Diagnostic Devices and Therapeutics by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer